BBS

Econolite and ZincFive Expand Partnership to Deliver More Sustainable Power Solutions to the Global ITS Market

Retrieved on: 
Tuesday, October 31, 2023
Hardware, Manufacturing, Other Manufacturing, Batteries, Technology, ITS, Uninterruptible power supply, BBS, CO, Intelligent transportation system, Nikolay Umov, Trust, Transport, Partnership, Nickel–zinc battery, Safety, ZincFive, UPS, Mobile phone

As part of the license agreement, Econolite has worldwide rights to manufacture, sell, support, and service the industry-leading NiZn-based Uninterruptible Power Supply (UPS) and Battery Backup System (BBS) solutions in the ITS market.

Key Points: 
  • As part of the license agreement, Econolite has worldwide rights to manufacture, sell, support, and service the industry-leading NiZn-based Uninterruptible Power Supply (UPS) and Battery Backup System (BBS) solutions in the ITS market.
  • “We are thrilled that ZincFive has chosen to expand our partnership, reaffirming their trust in Econolite’s ability to deliver on a global scale,” said Christian U. Haas, Econolite CEO.
  • “ZincFive is excited to partner with Econolite to expand the availability of our safe, reliable, and sustainable technology,” said ZincFive CEO and Co-Founder Tim Hysell.
  • “This partnership is founded on our common vision for a green, efficient future for the intelligent transportation industry.

Hong Kong Web3 Festival 2024 Set to Take Place 6-9 April, 2024

Retrieved on: 
Friday, November 3, 2023
JP, Government, GBM, Security (finance), Innovation, Technology and Industry Bureau, BBS, Technology and Innovation (constituency), Animoca Brands, Hong Kong Trade Development Council, CZ, Protocol, Alibaba Group, Securities and Futures Commission, OKX, GBS, Hong Kong Science and Technology Parks Corporation, Hong Kong Monetary Authority, Legislative council, YAN, InvestHK, MH, Nifedipine, InterPlanetary File System, Property management, Cryptocurrency, Fintech, Cyberport

HONG KONG, Nov. 2, 2023 /PRNewswire/ -- On Nov.3, Feng Xiao, Chairman of Wanxiang Blockchain and HashKey Group announced at Hong Kong Fintech Week that Hong Kong Web3 Festival 2024 will take place from 6-9 April, 2024.

Key Points: 
  • HONG KONG, Nov. 2, 2023 /PRNewswire/ -- On Nov.3, Feng Xiao, Chairman of Wanxiang Blockchain and HashKey Group announced at Hong Kong Fintech Week that Hong Kong Web3 Festival 2024 will take place from 6-9 April, 2024.
  • Built upon its record-breaking 2023 event, HK Web3 Festival 2024 will feature an amazing lineup of industry guests from around the globe.
  • The inaugural Web3 Festival, hosted on five center stages, brought together the world's brightest minds, top Web3 projects and leading venture capitals presenting content-rich discussions and topics centered around Web3.
  • In-depth talks and discussions were held around AIGC, privacy computing, Web3 security, Web3 infra, Fintech, DePIN, etc.

Hong Kong Web3 Festival 2024 Set to Take Place 6-9 April, 2024

Retrieved on: 
Friday, November 3, 2023
JP, Government, GBM, Security (finance), Innovation, Technology and Industry Bureau, BBS, Technology and Innovation (constituency), Animoca Brands, Hong Kong Trade Development Council, CZ, Protocol, Alibaba Group, Securities and Futures Commission, OKX, GBS, Hong Kong Science and Technology Parks Corporation, Hong Kong Monetary Authority, Legislative council, YAN, InvestHK, MH, Nifedipine, InterPlanetary File System, Property management, Cryptocurrency, Fintech, Cyberport

HONG KONG, Nov. 3, 2023 /PRNewswire/ -- On Nov.3, Feng Xiao, Chairman of Wanxiang Blockchain and HashKey Group announced at Hong Kong Fintech Week that Hong Kong Web3 Festival 2024 will take place from 6-9 April, 2024.

Key Points: 
  • HONG KONG, Nov. 3, 2023 /PRNewswire/ -- On Nov.3, Feng Xiao, Chairman of Wanxiang Blockchain and HashKey Group announced at Hong Kong Fintech Week that Hong Kong Web3 Festival 2024 will take place from 6-9 April, 2024.
  • Built upon its record-breaking 2023 event, HK Web3 Festival 2024 will feature an amazing lineup of industry guests from around the globe.
  • The inaugural Web3 Festival, hosted on five center stages, brought together the world's brightest minds, top Web3 projects and leading venture capitals presenting content-rich discussions and topics centered around Web3.
  • In-depth talks and discussions were held around AIGC, privacy computing, Web3 security, Web3 infra, Fintech, DePIN, etc.

Rhythm Pharmaceuticals Presents Data from its Long-term Extension Study of Setmelanotide Showing Sustained and Deepened BMI Reduction in Patients with Hypothalamic Obesity at One Year at ObesityWeek® 2023

Retrieved on: 
Tuesday, October 17, 2023
BMI, Obesity, POMC, Weight loss, LEPR, Bardet–Biedl syndrome, Setmelanotide, MC4R, BBS, Conference call, Disease, WHO, World Health Organization, Hypothalamic disease, Conference, Polyphagia, NIH, Birth control, Pharmaceutical industry, Nursing, Rhythm, Patient

BOSTON, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced several data presentations showing that setmelanotide therapy resulted in sustained and deepened weight loss in patients with severe obesity caused by rare MC4R pathway diseases during The Obesity Society’s Annual Meeting at ObesityWeek®.

Key Points: 
  • Rhythm and its collaborators delivered a total of six presentations at the conference in Dallas from October 14 to 17.
  • In addition, the Company will host an investor conference call and webcast to discuss these data presentations on Wednesday, October 18, 2023, at 8:00 a.m.
  • This conference call will be accessible under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com.
  • A replay will be available on the Rhythm website for 30 days following the presentation.

BDO announces winners of the 5th BDO ESG Awards 2023

Retrieved on: 
Friday, October 13, 2023
OBE, Sino Group, Climate change, CLP Group, Copy, Stock exchange, Environmental, social, and corporate governance, ESG, Climate, Risk management, The Hong Kong University of Science and Technology, COVID, JP, SCMP, Carbon, BBS, The Morning Post, The Sydney Stock Exchange, NEXT Woman of the Year awards, SBS, Benchmarking, BDO, HKET, Biophysical environment, Film industry, Accounting, Renewable energy, Award

HONG KONG, Oct 13, 2023 - (ACN Newswire) - BDO, the world's fifth largest accountancy and advisory network, announced the winners of the 5th BDO ESG Awards (the Awards), comprising listed companies in Hong Kong that have made a positive impact in the Environmental, Social, and Governance (ESG) domains through the implementation of outstanding sustainability initiatives.

Key Points: 
  • HONG KONG, Oct 13, 2023 - (ACN Newswire) - BDO, the world's fifth largest accountancy and advisory network, announced the winners of the 5th BDO ESG Awards (the Awards), comprising listed companies in Hong Kong that have made a positive impact in the Environmental, Social, and Governance (ESG) domains through the implementation of outstanding sustainability initiatives.
  • The winners were made known during the BDO ESG Awards Presentation Ceremony, which is the first physical awards presentation ceremony to be held since the COVID outbreak.
  • Photo 1: Representatives of BDO and panel of judges attend the BDO ESG Awards 2023 Presentation Ceremony.
  • Photo 3: A group photo comprising representatives of award winners, BDO, SCMP, HKET and judging panel and supporting organisations at the BDO ESG Awards Presentation Ceremony.

Introducing the new Porsche 911 GT3 R rennsport

Retrieved on: 
Friday, September 29, 2023
Dark, Balance of performance, Metallic, FIA, Brumos Racing, Ventilation, Dauer 962 Le Mans, Michelin, Overalls, Eye, Gasoline, Tax, Porsche Rennsport Reunion, AP, GT2, GT3, Corkscrew, Porsche 911 GT3, Language, History, Carbon, BBS, Porsche Design, Running, LED, Porsche in motorsport, E25, KW, WeatherTech Raceway Laguna Seca, Bop, Skin, Safety, RSR, Cassette tape, Video game, Telescopic sight, Paint, Daytona, Porsche

The 911 GT3 R rennsport, with a power output of up to 611 hp, is based on the new 911 GT3 R of the current 992 generation.

Key Points: 
  • The 911 GT3 R rennsport, with a power output of up to 611 hp, is based on the new 911 GT3 R of the current 992 generation.
  • The Porsche 911 GT3 R rennsport combines the powerful appearance of a high-performance race car with modern design elements.
  • "The 911 GT3 R rennsport will take its place as the logical successor to the modern Porsche 935, itself revealed at Rennsport Reunion 6 in 2018.
  • While the 935 was technically based on the near-standard 911 GT2 RS Clubsport, the 911 GT3 R rennsport uses the current 911 GT3 R of the 992 generation as its basis.

Rhythm Pharmaceuticals Presents New Data at ESPE 2023

Retrieved on: 
Friday, September 22, 2023
Polyphagia, LEPR, Adolescent medicine, University of Alberta, Risk, Obesity, University, Pediatrics, Metabolic syndrome, Doctor of Philosophy, Genetics, Pediatric endocrinology, Bardet–Biedl syndrome, ESPE, Endocrine Society, POMC, ROAD, BBS, Early-onset Alzheimer's disease, Patient, Division, Endocrinology, University of Ulm, Medicine, Body mass index, MC4R, European Society for Paediatric Research, Imperial College London, Proopiomelanocortin, Vaccine, Nursing, Rhythm, The Hague

BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced four oral presentations at the 61st Annual European Society for Paediatric Endocrinology (ESPE) Meeting being held September 21-23, 2023 in The Hague, Netherlands.

Key Points: 
  • BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today announced four oral presentations at the 61st Annual European Society for Paediatric Endocrinology (ESPE) Meeting being held September 21-23, 2023 in The Hague, Netherlands.
  • “We are excited to deliver multiple presentations at ESPE 2023 including statistics that deepen the understanding of the genetics of obesity from our Rare Obesity Advanced Diagnosis™ (ROAD) testing program as we learn more about the importance of genetics in patients with early-onset, severe obesity,” said David Meeker, M.D., Chair, President and Chief Executive Officer of Rhythm.
  • “Frequency of Obesity-Related Gene Variants in a European Population with Early-Onset, Severe Obesity,” as presented orally by Jesús Argente M.D., Ph.D., Department of Pediatrics and Pediatric Endocrinology, Universidad Autónoma de Madrid in Spain, shows that among individuals with early-onset, severe obesity, approximately 31.4% carried variants believed to be associated with obesity.
  • In addition, Rhythm is hosting a satellite symposium at ESPE 2023, titled, “Hyperphagia and early-onset, severe obesity: The role of precision medicine in the treatment of leptin melanocortin-4 receptor (MC4R) pathway diseases.”

ALSA Ventures launches novel Gene Therapy portfolio company Axovia Therapeutics to treat Ciliopathies

Retrieved on: 
Tuesday, September 19, 2023
Tissue, University College London, UCL, PRV, BBS1, Research, Paratriathlon, Disease, AAV, BBS, Acquisition, ALSA, Patient, Syndrome, Vazgen Safarian, Ciliopathy, FDA, Therapy, Health, Pharmaceutical industry, Vaccine, Nursing, Child, Voretigene neparvovec

LONDON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- ALSA Ventures , a UK-based, therapeutics-focused venture capital fund, announces the acquisition of Axovia Therapeutics Inc and the launch of a new portfolio company Axovia Therapeutics Ltd .

Key Points: 
  • LONDON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- ALSA Ventures , a UK-based, therapeutics-focused venture capital fund, announces the acquisition of Axovia Therapeutics Inc and the launch of a new portfolio company Axovia Therapeutics Ltd .
  • Axovia is developing the first gene therapies for ciliopathies and has a pipeline of products for these devastating diseases, including Bardet-Biedl Syndrome (BBS).
  • AXV101 is an AAV9-based gene therapy targeting retinal dystrophy associated with BBS in patients carrying biallelic mutations in the BBS1 gene.
  • Axovia Acting CEO Professor Phil Beales said the Axovia gene therapy platform gives hope to BBS patients worldwide.

Rhythm Pharmaceuticals Announces New ICD-10 Diagnosis Code Established for Bardet-Biedl Syndrome

Retrieved on: 
Wednesday, September 6, 2023
Polyphagia, Obesity, International Classification of Diseases, Prevalence, Bardet–Biedl syndrome, Deficit spending, Visual impairment, Knowledge Organization (journal), Brain, CDC, BBS, HIV disease progression rates, Patient, Physician, Syndrome, Korea Disease Control and Prevention Agency, Hypothalamus, MC4R, Diagnosis, Hunger, News, Hypogonadism, Polydactyly, Disease, Pharmaceutical industry, Nursing

The new code, Q87.83 Bardet-Biedl syndrome (BBS), takes effect Oct. 1, 2023.

Key Points: 
  • The new code, Q87.83 Bardet-Biedl syndrome (BBS), takes effect Oct. 1, 2023.
  • “Finding and connecting patients, families and physicians across the country has been extremely challenging because of the lack of a dedicated ICD-10 code as patients with BBS are lumped in with many other genetic syndromes,” said Tim Ogden, President of the BBS Foundation.
  • “We believe this new disease specific ICD-10 code marks an important advance for the care of patients with BBS,” said Jennifer Chien, Rhythm Executive Vice President and Head of North America.
  • People living with BBS also may experience cognitive impairment, polydactyly, renal dysfunction, hypogonadism, and visual impairment.

Veeder-Root and Total Meter Services Launch the Biofuel Blending System

Retrieved on: 
Tuesday, August 29, 2023
Partnership, Gilbarco Veeder-Root, AIS, Red, ATG Stores, Biofuel, BBS, Longevity, Total, Jet fuel, Renewable energy, Twitter

Simsbury, CT, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Veeder-Root, a worldwide leader in fuel management and environmental technology, in collaboration with precision measurement solutions expert Total Meter Services, proudly presents the Biofuel Blending System (BBS).

Key Points: 
  • Simsbury, CT, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Veeder-Root, a worldwide leader in fuel management and environmental technology, in collaboration with precision measurement solutions expert Total Meter Services, proudly presents the Biofuel Blending System (BBS).
  • This in-line solution utilizes the same technology as the highly successful Additive Injection System (AIS), offering a versatile and accurate biofuel blending solution designed specifically for retail locations.
  • As part of the reputable Veeder-Root brand, the Biofuel Blending System is supported by the largest distribution network in the industry.
  • "We are excited to introduce the Biofuel Blending System in partnership with Total Meter Services," said Steve Coppola, Director of Product for Veeder-Root.